| |
Etiology of secondary hypertension arterial hypertension
from wikipedia.org
Only in a small minority of patients with elevated arterial pressure, can a specific cause be identified. arterial hypertension These individuals will probably have an endocrine or renal defect that, if corrected, could bring blood pressure back to normal values.
- Renal hypertension arterial hypertension
- Hypertension produced by diseases of the kidney. This includes diseases such as polycystic kidney disease or chronic glomerulonephritis. Hypertension can also be produced by diseases of the renal arteries supplying the kidney. This is known as renovascular hypertension; arterial hypertension it is thought that decreased perfusion of renal tissue due to stenosis of a main or branch renal artery activates the renin-angiotensin system.
- Adrenal hypertension
- Hypertension is a feature of a variety of adrenal cortical abnormalities. arterial hypertension In primary aldosteronism there is a clear relationship between the aldosterone-induced sodium retention and the hypertension.
- In patients with pheochromocytoma increased secretion of catecholamines such as epinephrine and norepinephrine by a tumor arterial hypertension (most often located in the adrenal medulla) causes excessive stimulation of [adrenergic receptors], which results in peripheral vasoconstriction and cardiac stimulation. This diagnosis is confirmed by demonstrating increased urinary excretion of epinephrine and norepinephrine and/or their metabolites arterial hypertension (vanillylmandelic acid).
- Coarctation of the aorta
- Diet
- The North American diet that is high in fat and salt has been proven to exacerbate hypertension. arterial hypertension A study in the U.S. found that patients placed on a strict vegetarian diet showed a significant benefit to their condition over the one year. Certain medications, especially NSAIDS (Motrin/ibuprofen) and steroids can cause hypertension. arterial hypertension Imported licorice (Glycyrrhiza glabra) inhibits the 11-hydroxysteroid hydrogenase enzyme (catalyzes the reaction of cortisol to cortison) arterial hypertension which allows cortisol to stimulate the Mineralocorticoid Receptor (MR) which will lead to effects similar to hyperaldosteronism, which itself is a cause of hypertension. arterial hypertension [Reference: Harrisons Internal Medicine, online edition (2007-04-14)]
- Age
- Over time, the number of collagen fibers in artery and arteriole walls increases, arterial hypertension making blood vessels stiffer. With the reduced elasticity comes a smaller cross-sectional area in systole, and so a raised mean arterial blood pressure.
Hypertension - Wikipedia, the free encyclopedia
... formally called arterial hypertension, the word "hypertension" without a ... for the increased arterial pressure in some patients with hypertension. ...
Pulmonary arterial hypertension - Genetics Home Reference
Pulmonary arterial hypertension is a progressive disorder ... on treatment of pulmonary arterial hypertension in Educational resources and Patient support. ...
What Is Pulmonary Arterial Hypertension?
Pulmonary arterial hypertension (PAH) is continuous high blood pressure in the pulmonary artery. ... Primary pulmonary arterial hypertension (PPAH) is ...
Hypertension
... blood pressure in systemic arterial hypertension may be associated with an ... endogenous peptide mediator that has a role in pulmonary arterial hypertension. ...
Pulmonary hypertension - Wikipedia, the free encyclopedia
Common causes of pulmonary arterial hypertension (PAH) include HIV, scleroderma ... Symposium on Pulmonary Arterial Hypertension was convened in Venice ...
PAH | Pulmonary Arterial Hypertension | Medscape
Medscape's Pulmonary Arterial Hypertension Resource Center provides a comprehensive medium containing the most up-to-date and clinically relevant material relating ...
Hypertension Online Slides - mean arterial pressure, mean arterial pressure
Clinical Trials in Hypertension and Renal Diseases ... Arterial hypertension accelerates renal disease and hastens the progression to ...
Pulmonary Arterial Hypertension
Pulmonary arterial hypertension is defined as a sustained elevation of ... idiopathic pulmonary arterial hypertension (formerly, primary pulmonary hyperten ...
Pulmonary Arterial Hypertension, Respironics
Information on Pulmonary Arterial Hypertension from Respironics ... Pulmonary arterial hypertension (PULL-mo-na-ree hi-per-TEN-shun) or PAH is a ...
pulmonary arterial hypertension, PAH
pulmonary arterial hypertension - Cleveland Clinic Department of Pulmonary, in Cleveland Ohio specializes in the treatment of PAH.
SPA therapy of arterial hypertension
... female) with stage II arterial hypertension characterized by stabile increase in ... 30-55 years old with arterial hypertension pre-existent for 5-20 years. ...
Amazon.com: arterial hypertension
Arterial Hypertension /or Morphologic and Functional Contributions to the ... Arterial Hypertension, Caracas, August 29-September 1, 1979 (International ...
Treatment of Pulmonary Arterial Hypertension
... unclear whether the various types of pulmonary arterial hypertension share a com ... monary arterial hypertension does not preclude an ...
Primary and secondary prevention of arterial hypertension
Arterial hypertension is a clinical condition characterized by increased ... this context on the "secondary arterial hypertension" conditions due to other ...
MedlinePlus: Pulmonary Hypertension
Pulmonary Arterial Hypertension(National Heart, Lung, and Blood Institute) ... Home Reference: Pulmonary arterial hypertension(National Library of Medicine) ...
Letairis Treats Pulmonary Arterial Hypertension - High Blood Pressure (hypertension) and related information on ...
... includes high blood pressure (hypertension), low blood pressure (hypotension) ... pressure a-z list > letairis treats pulmonary arterial hypertension article ...
Arterial Hypertension
Arterial hypertension. Systemic arterial hypertension is defined as ... or primary, hypertension is systemic arterial hypertension of unknown cause; ...
What Causes Pulmonary Arterial Hypertension?
Certain conditions appear to increase your chances of developing PAH. ... Secondary pulmonary arterial hypertension (SPAH) is caused by a variety of conditions. ...
Disease Category Listing (702): Pulmonary Arterial Hypertension
CenterWatch Listing of Clinical Research Trials for Pulmonary Arterial Hypertension ... drug Patients with Pulmonary Arterial Hypertension Receiving Oral Sildenafil. ...
PHCentral - Pulmonary Arterial Hypertension: The Complete Resource
Resources about pulmonary hypertension. Includes articles, research, glossary of terms, and message boards.
Pulmonary arterial hypertension definition - Medical Dictionary definitions of popular medical terms easily defined ...
Online Medical Dictionary and glossary with medical definitions ... Arterial Hypertension. Combination Therapy Eases Pulmonary Arterial Hypertension. Health ...
Pulmonary Arterial Hypertension in France: Results From a National Registry - Health - RedOrbit
... Et al Rationale: Pulmonary arterial hypertension (PAH) is an orphan disease ... Center for Pulmonary Arterial Hypertension (Hpital Antoine Bclre, Clamart, ...
Triumph-1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint (The San Francisco Examiner)
SILVER SPRING, Md. ( Map ) - SILVER SPRING, Md., Nov. 1 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR ) and its wholly-owned subsidiary, Lung Rx, Inc., announced today the completion of their TRIUMPH-1 Phase 3 trial of Viveta, an inhaled formulation of treprostinil, in pulmonary arterial hypertension (PAH).
Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on ... (The San Francisco Examiner)
SILVER SPRING, Md. ( Map ) - SILVER SPRING, Md., Oct. 31 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR ) and its wholly-owned subsidiary, Lung Rx, Inc., announced today that they will release the results of their TRIUMPH-1 Phase 3 trial of Viveta, an inhaled formulation of treprostinil, in pulmonary arterial hypertension (PAH) before market open on Thursday, November 1, ...
Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on ... (PR Newswire via Yahoo! Finance)
United Therapeutics Corporation and its wholly-owned subsidiary, Lung Rx, Inc., announced today that they will release the results of their TRIUMPH-1 Phase 3 trial of Viveta, an inhaled formulation of treprostinil, in pulmonary arterial hypertension before market open on Thursday, November 1, 2007.
Specialized Search Engine Results can be Found by Clicking on Your Favorite Search Engine Below!
Google MSN Ask Jeeves Look Smart DMOZ Yahoo Searchalot Earthlink Mamma Dogpile AOL iWon Searchre Overture
blood high hypertension new pressure prevent program reduce reversing treat vital cause of pulmonary hypertension dietary approach to stop hypertension high blood pressure hypertension symptom hypertension article hypertension during pregnancy hypertension exercise hypertension headache hypertension in pregnancy hypertension kidney hypertension management hypertension medication hypertension risk factor intracranial hypertension natural remedy for hypertension natural treatment for hypertension ocular hypertension pathophysiology of hypertension pediatric hypertension portal hypertension primary hypertension pulmonary hypertension symptom renovascular hypertension stage 1 hypertension stage 2 hypertension
Home | Index | arterial hypertension
|
Unlock More!
food
seizures
epilepsy
antidepressants
bloodpressure
headache
strokes
|
